Skip to main content
May 11, 2021
Dr. Moriarty reviews devices and techniques that help to remove the afterload on the right ventricle in submassive pulmonary embolism.
May 11, 2021
Dr. John H. Rundback discusses a report from the Pathfinder registry that takes a look at using the Auryon laser for PAD, the utilization of tacks in tibial interventions, and TOBA II BTK 12-month results.
May 11, 2021
Dr. Robert E. Beasley discuss treatment options for tibioperoneal disease. He highlights how there is only one FDA-approved treatment option available for below-the-knee tibial vessels—balloon angioplasty. He reviews other options such as…
May 11, 2021
Endovascular approaches to complex aortic arch aneurysms and dissections require creativity, learning from the work of others, and continued innovation from industry partners, according to Jason T. Lee, MD (Stanford University) in a presentation he…
May 11, 2021
Currently about one third of all endovascular procedures and 25% of all lower extremity arterial revascularization procedures are performed in an office-based setting. These numbers are expected to increase by a record setting 5% per year, over the…
May 11, 2021
Presenting an update on the COMPARE trial, Marianne Brodmann, MD, from Medical University Graz in Graz, Austria split her presentation into 2 parts: the first, 1-year data from the RANGER II SFA long lesion cohort, and the second, a 2-year update of…
May 11, 2021
There are basically 3 camps in this discussion of how patients should be anticoagulated after endovascular intervention, according to Raghu Kolluri, MD, from OhioHealth and Ohio University.
May 11, 2021
Dr. Fadi Saab discusses which scenarios are ideal for use of atherectomy in below-the-knee lesions. He reviews the most recent data from trials and registries such as XLPAD, LIBERTY 360, and many more.
May 11, 2021
Dr. Daniel Clair discusses which problems can be encountered during interventions for aortic occlusion and outlines various therapeutic strategies to improve outcomes.
May 11, 2021
Dr. Anthony Lee discusses both early and late types of endograft failures, including type I, II, and III endoleaks as well as the methods that can be employed at various stages to avoid poor outcomes.
Back to Top